Remove authors ian-manners
article thumbnail

The benefits of mass spectrometry for expediting biologics to patients

European Pharmaceutical Review

Approaching characterisation of complex molecules from both a drug product and drug substance perspective in a holistic manner, with previous technical experience combined with cutting edge technologies, can enable delivery of successful CMC outcomes. Ian has previously worked for Allergan, AbbVie and Pharmaron gene therapy.

82
article thumbnail

3D printing and personalised medicines: embracing innovative technologies

Hospital Pharmacy Europe

Ian Soulairol from the Institut Charles Gerhardt Montpellier at Montpellier University and pharmacist at the Department of Pharmacy of Nîmes University Hospital in France shares insights into how this technology is evolving and what it means for clinical practice now and in the future. These include printing time, temperature, etc.,

Hospitals 111